Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma

Authors

Institutions

Publication Details

Journal
Future Oncology
Published
2025-05-27
DOI
https://doi.org/10.1080/14796694.2025.2507561
Citations
3
Primary Topic
CNS Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma

Ryo Nishikawa, Koji Izutsu, Ichiro Matsumoto, Akira Kawasaki
3 citations
Future Oncology
CNS Lymphoma Diagnosis and Treatment
4.17
article

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma

Ryo Nishikawa, Koji Izutsu, Ichiro Matsumoto, Akira Kawasaki
article en
3 citations

Abstract

No abstract available for this paper.
Future OncologyVol. 21(15)
National Cancer Center (US), Ono Pharmaceutical (Japan) (JP), Saitama International Medical Center (JP), Tokyo National Hospital (JP), Saitama Medical University (JP)
Ono Pharmaceutical
Openalex Percentile: Top 6%
CNS Lymphoma Diagnosis and Treatment
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.